![Aileen Wang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Aileen Wang is currently the Chief Financial Officer at Clover Biopharmaceuticals Ltd. She previously worked at Novartis Gene Therapies, Inc. as the Head-Core Business Planning & Analysis.
Ms. Wang holds an MBA from The Pennsylvania State University and an undergraduate degree from Shanghai Jiao Tong University.
| Companies | Position | Start |
|---|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Director of Finance/CFO | 01/07/2022 |
| Companies | Position | End |
|---|---|---|
| AVEXIS INC | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 4 |
|---|---|
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai Jiao Tong University
 Shanghai Jiao Tong University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage gene therapy company | Health Technology |
Clover Biopharmaceuticals Ltd.
 Clover Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
